Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsWalter Kernan, MD, senior research scientist at Yale University, discussed the latest primary stroke prevention guidelines and their focus on lifelong brain health and risk factor management.
Andy Berkowski, MD, PhD, certified sleep neurologist and author of the RLS guidelines, spoke about the clinical impact of the recently published restless syndrome guidelines.
FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma
Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma
IgA Nephropathy Prediction Model Aids 5-Year Survival Estimation
Increased Physical Activity Linked to Reduced Mortality In Peritoneal Dialysis
GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM
1.
Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.
2.
Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Kate Middleton Reaches Cancer Treatment Milestone
5.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
1.
Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results
2.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
3.
Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care
4.
Glycopyrrolate: The Secret Weapon for Excessive Sweating
5.
Polycythemia Vera: A Historical Perspective and Contemporary Management
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
3.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge